HealthRX vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

53 providers verified independently·Independent research·How we rank →

Visit MEDVi - our pick of these two→or find your match

MEDVi beats HealthRX overall, scoring 7.7/10 vs 5.2/10. HealthRX is more affordable at $99/mo vs $179/mo. Choose HealthRX for cash-pay patients who want low flat-dose compounded glp-1 pr. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side look at HealthRX and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

HealthRX

#50 of 53

5.2/10

HealthRX is a cash-pay telehealth platform for compounded injectable semaglutide and tirzepatide. Its July 2026 landing page lists semaglutide at $133/mo on a 3-month plan or $99/mo on a 12-month plan, plus tirzepatide at $209/mo or $179/mo. Prices stay flat across doses and include clinician review, dose adjustments, and overnight shipping. MD Integrations supplies the clinician network, while the dispensing 503A pharmacy remains unnamed on the public site.

Visit HealthRX

Higher Rated

MEDVi

#20 of 53

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	HealthRX	MEDVi
Our Score	5.2/10	7.7/10
Starting Price	$99/mo	$179/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Cash-pay patients who want low flat-dose compounded GLP-1 pricing, all-50-state access, fast shipping, and self-service cancellation	Users who want a low entry price with oral and injectable compounded options
Ranking	#50	#20
Get started	Visit HealthRX	Visit MEDVi

Pros & Cons Compared

HealthRX

Pros

+$99/mo compounded semaglutide on the 12-month plan, with a $133/mo 3-month option
+Flat pricing across doses, clinician review, dose adjustments, and overnight shipping included
+Licensed clinicians in all 50 states through MD Integrations, with most files reviewed within about 24 hours
+LegitScript certificate 50087439 links to the issuer's verification checker
+Single-click account cancellation and refunds for unshipped doses
+Published HIPAA notice, telehealth consent, safety information, and emergency instructions

Cons

−The dispensing 503A pharmacy is described by type while its name and license remain absent from the public site
−Legal entity, headquarters, executive team, and medical director remain undisclosed
−The tirzepatide product page advertises $149/mo while the current affiliate landing and FAQ say $179/mo, so confirm the checkout rate
−The 4.8/5 from 12,000+ members block uses illustrative composites rather than an independent review platform
−Cash-pay only, with no insurance billing or prior-authorization support
−Compounded medications sit outside FDA premarket approval as finished products

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Our Verdict

MEDVi edges out HealthRX with a score of 7.7/10 vs 5.2/10. If budget is your priority, HealthRX starts at $99/mo compared to MEDVi's $179/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose HealthRX if you want: cash-pay patients who want low flat-dose compounded glp-1 pricing, all-50-state access, fast shipping, and self-service cancellation. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's Featured Pick

TrimRx

$149/mo · 7.8/10 · Compounded

If neither HealthRX nor MEDVi feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.

Visit TrimRx→Read our full TrimRx review